Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
05/2002
05/15/2002CN1349502A Method for the prepn. of tricyclic amino alcohol derivatives through azides
05/15/2002CN1349501A Novel method for mfg. tricyclic amino alcohol derivatives
05/15/2002CN1349500A 3,3-substituted indoline derivatives
05/15/2002CN1349499A Thio-oxindole derivatives
05/15/2002CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors
05/15/2002CN1349497A Monofluoroalkyl derivatives
05/15/2002CN1349417A Contraceptive compositions containing 3,3-substituted indoline derivatives and use thereof
05/15/2002CN1349416A Contraceptive compositions contaiing indoline derivatives and progestational agents
05/15/2002CN1084751C Palladium catalyzed indolization
05/15/2002CN1084748C Aminomethyl-2,3,8,9-terahydro-7H-1,4,-dioxino [2,3-e]-indol-8-ones and derivatives
05/14/2002US6388123 Substituted phenyl keto enols as pesticides and herbicides
05/14/2002US6388105 Antiproliferative agents; skin disorders; antiinflammatory agents
05/14/2002US6388095 Indole-containing quaternary ammonium compounds
05/14/2002US6388091 In presence of a halosilane compound; crystallization, purification
05/14/2002US6388078 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
05/14/2002US6387941 Antiserotonine agents
05/14/2002US6387937 Indole derivatives
05/14/2002US6387932 Somatostatin agonists
05/14/2002US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/14/2002CA2202030C Method for reducing unwanted cellular adhesions
05/14/2002CA2075876C Arylethylamines derivatives, process for their preparation and pharmaceutical compositions holding same
05/10/2002WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002WO2002036564A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
05/10/2002WO2002036563A1 Crystalline forms of fluvastatin sodium
05/10/2002WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
05/10/2002WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002WO2002036547A1 Cyclopropanecarboxylic acid amide compounds and medicinal use thereof
05/10/2002WO2002036544A1 Method of resolving optical isomers of amino acid derivative
05/10/2002WO2002036115A1 Sulphonamides for the treatment of central nervous system diseases
05/10/2002WO2002036075A2 Small molecule compositions for binding to hsp90
05/10/2002WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
05/10/2002WO2000075237A9 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS
05/10/2002CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
05/10/2002CA2426977A1 Sulphonamides for the treatment of central nervous system diseases
05/10/2002CA2426395A1 Crystalline forms of fluvastatin sodium
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/09/2002US20020055635 Cycloalkano-indole and -azaindole derivatives
05/09/2002US20020055631 N-acylsulfonamide apoptosis promoters
05/09/2002US20020055630 Process for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indole derivatives
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/09/2002US20020055510 Useful in the treatment of cancer.
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055504 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product
05/09/2002US20020055171 Generation of preferential compounds by photoactivation of indole-3-acetic acid; obtain indole-3-acetic acid, photoactivate, recover preferential compounds
05/09/2002US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders
05/08/2002EP1203047A1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors
05/08/2002EP1202968A2 Antibacterial agents
05/08/2002EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application
05/08/2002EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
05/08/2002EP1202963A1 Spla2 inhibitors
05/08/2002EP1202956A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
05/08/2002EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives
05/08/2002EP1202945A1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
05/08/2002EP1202718A2 Substituted guanidines for the treatment of cancer and pain
05/08/2002EP0888301A4 Mcbi analogs of cc-1065 and the duocarmycins
05/08/2002DE10053813A1 Neue Verwendung von Sulfonamiden New use of sulfonamides
05/08/2002DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists
05/07/2002US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors
05/07/2002US6384235 Preparation of substituted indoles
05/07/2002US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/07/2002US6384070 Restenosis, kidney diseases, lung diseases
05/07/2002US6384069 Brain disorders chronic pain, hypoglycemia, hypoxia, trauma, alzheimer's disease, aids-associated dementia, amyotrophic lateral sclerosis, parkinson's disease, and chronic alcoholism, comprising administering to a patient in need a
05/02/2002WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002WO2002034760A2 Compounds and methods
05/02/2002WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034718A1 Amide derivatives as nmda receptor antagonists
05/02/2002WO2002034717A1 Sulphur-containing indirubin derivatives, production and use thereof
05/02/2002WO2002034711A1 Biaryl compounds as serine protease inhibitors
05/02/2002WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
05/02/2002WO2001081306A3 Azide cyclization-based synthesis and intermediates for spla2 inhibitors
05/02/2002WO2001081305A3 Methylation of indole compounds using dimethy carbonate
05/02/2002WO2001081298A3 Cyclic carboxylic acids as integrin antagonists
05/02/2002WO2001023353A3 Method for producing indole derivatives on a solid phase
05/02/2002WO2000061124A3 Use off cell membrane penetrating indigoid bisindole derivatives
05/02/2002US20020052496 Novel 1-(N'-(arylalkylaminoalkyl)) aminoisoquinolines: a new class of dopamine receptor subtype
05/02/2002US20020052399 In particular as inhibitors of HIV protease.
05/02/2002US20020052398 Pharmaceutical composition of 6-amino EM-12
05/02/2002US20020052378 Novel compounds and compositions as protease inhibitors
05/02/2002US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder
05/02/2002US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors
05/02/2002US20020052343 Salicylamides as serine protease inhibitors
05/02/2002EP1202120A2 Charge transport compound, elctrophotographic organophotoreceptor comprising the same, and electrographic imaging apparatus and method
05/02/2002EP1200503A1 Process for the polymerisation of cycloolefins and polymerisable cycloolefins
05/02/2002EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
05/02/2002EP1200404A2 Process for the preparation of spiro[(4-cyclohexanone)- [3h] indol-2'[1'h]-one derivatives
05/02/2002EP1200403A2 Process for the preparation of spiro(cis-4-(beta-hydroxyethyloxy) cyclohexane-(3h) indol)-2'(1'h)-one derivatives
05/02/2002EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor
05/02/2002EP1200072A2 Method of treating psychotic disorders
05/02/2002EP0812838B1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
05/02/2002EP0615448B1 Sex steroid activity inhibitors
05/02/2002DE10053474A1 Schwefelhaltige Indirubinderivate, deren Herstellung und Verwendung Sulfur-containing indirubin derivatives, their preparation and use
05/02/2002CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002CA2426430A1 Biaryl compounds as serine protease inhibitors
05/02/2002CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/01/2002CN1083831C Novel tricyclic compounds and drug compositions contg. same
04/2002
04/30/2002US6380434 Fullerene derivatives
04/30/2002US6380412 Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof